Royal Bank of Canada »

Citius Oncology shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Citius Oncology (CTOR) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Citius Oncology

Tip: Access up to 7 years of quarterly data

All positions including Citius Oncology held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Oncology by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $0 186 0.00

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Citius Oncology

Armistice Capital
Bank of America Corporation
Vanguard Group
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
IFP Advisors
BlackRock
Northern Trust
State Street Corporation
UBS Group
Arkadios Wealth Advisors
Advisor Group Holdings
Royal Bank of Canada
Caitong International Asset Management

View all funds holding Citius Oncology